The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: a report on the medical research council UKALLR1 study.
about
Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trialOutcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and MarPrevention of bacterial infection in pediatric oncology: what do we know, what can we learn?Temporal changes in the incidence and pattern of central nervous system relapses in children with acute lymphoblastic leukaemia treated on four consecutive Medical Research Council trials, 1985-2001.Long-term follow-up of the United Kingdom medical research council protocols for childhood acute lymphoblastic leukaemia, 1980-2001Pathogenesis of ETV6/RUNX1-positive childhood acute lymphoblastic leukemia and mechanisms underlying its relapseA therapeutic trial of decitabine and vorinostat in combination with chemotherapy for relapsed/refractory acute lymphoblastic leukemia.High-risk pediatric acute lymphoblastic leukemia: to transplant or not to transplant?Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: a Children's Oncology Group study.Feasibility Study of a Novel Experimental Induction Protocol Combining B43-PAP (Anti-CD19) Immunotoxin With Standard Induction Chemotherapy in Children and Adolescents With Relapsed B-Lineage ALL: A Report From the Children's Oncology GroupChildhood acute lymphoblastic leukaemia and relapse.Location, movement and survival: the role of chemokines in haematopoiesis and malignancy.Relapsed childhood acute lymphoblastic leukemia in the Nordic countries: prognostic factors, treatment and outcome.Survival following relapse in childhood haematological malignancies diagnosed in 1974-2003 in Yorkshire, UKChildhood leukaemia: long-term excess mortality and the proportion 'cured'.Familial T-cell non-Hodgkin lymphoma caused by biallelic MSH2 mutationsReinduction platform for children with first marrow relapse of acute lymphoblastic Leukemia: A Children's Oncology Group Study[corrected]Central nervous system involvement in adult acute lymphoblastic leukemia.Hematopoietic cell transplantation for children with acute lymphoblastic leukemia in second complete remission: similar outcomes in recipients of unrelated marrow and umbilical cord blood versus marrow from HLA matched sibling donorsImproving outcomes for high-risk ALL: translating new discoveries into clinical care.How to treat relapsed acute lymphoblastic leukemia: transplant vs. conventional chemotherapy.Disseminated fusariosis and endogenous fungal endophthalmitis in acute lymphoblastic leukemia following platelet transfusion possibly due to transfusion-related immunomodulationAllogeneic hematopoietic cell transplantation outcomes for children with B-precursor acute lymphoblastic leukemia and early or late BM relapse.Central nervous system relapse in adults with acute lymphoblastic leukemia.Outcome of risk adapted therapy for relapsed/refractory acute lymphoblastic leukemia in children.A single high dose of idarubicin combined with high-dose ARA-C for treatment of first relapse in childhood 'high-risk' acute lymphoblastic leukaemia: a study of the AIEOP group.Successful treatment without cranial radiotherapy of children receiving intensified chemotherapy for acute lymphoblastic leukaemia: results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI (ISRC TN 16757172).Outcome after first relapse in childhood acute lymphoblastic leukaemia - lessons from the United Kingdom R2 trial.Prediction of relapse in paediatric pre-B acute lymphoblastic leukaemia using a three-gene risk index.Population survival from childhood cancer in Britain during 1978-2005 by eras of entry to clinical trials.Increased expression of multidrug resistance gene (MDR1) at relapse in a child with acute lymphoblastic leukemia.
P2860
Q24621523-9F9BE299-C5A0-48CB-9D5F-7960BED091D4Q30444738-12BDCCEF-C88C-4754-9F87-0A9CED3727D7Q33559453-9D2CFC89-F52E-4AC0-874F-382E52FB6C17Q33647130-CC61FB10-EC8C-4690-9B51-8D208C09B81DQ33647139-D2709A7B-2FA2-4985-87AC-3990C1BCE3E3Q33798890-C1B98086-7ADB-4122-A376-07AD255290A1Q34052660-766E0F71-9E2D-4DD5-8646-B5413CD869E6Q34645259-3502F2F4-C1FD-4760-8DBE-7C8680D6AA16Q35848913-7E1D1E52-DD50-4CEC-9510-539195A1FBE1Q35953635-71669175-4B63-4B68-AD6F-992B3685F173Q36340652-88B62212-B467-45C9-8C92-69150097C3C6Q36366975-4A2A2372-02B7-4AC6-808E-FBA55F2EDEC7Q36420748-B6C65012-7659-4AF4-B03D-070C49845045Q36610199-6B8DB0E4-F981-494D-AF47-C2DBF7B321D0Q36755145-FB22C3FE-6CAD-4349-ACBB-17E7CB5B0685Q37004663-D3D1B1CE-B3D5-4916-9EF1-AECC576FF131Q37124911-EE165CE0-C4CA-4193-942E-660AAC80B31BQ37293534-B3806A53-FC35-470F-98C3-46A8057FB717Q37579597-F38B26D3-CE94-4AB2-8E7D-84125FDE412DQ37849259-8A29B661-7CAD-4BCE-B11C-29F116AB960EQ38102619-E2F57F7B-43B4-4066-9BEE-E2EF51F06C19Q39247582-2E361BE5-DFC8-455F-8D96-CB397E5592A2Q39835544-644728A8-ADF9-4255-8413-689F45F8E060Q40658607-BDE32D31-54B3-4616-932C-30FD53B67923Q43702779-0839B9C3-D768-4C4E-BD8A-0107273A0A3EQ44103814-48599652-A30D-413F-899D-E5CEA159FADCQ44693243-DF861885-E37C-41B5-BD9A-ACAF021317C6Q46569726-9FA92C1B-66A8-4525-AB0C-DBF20730E011Q46731902-1FA542CE-9EFA-4FED-926D-4C78736C280BQ47368648-46DA8BF7-A13A-48BA-98EE-EEB2C7F36390Q53610837-8A152692-BF2A-4513-8B22-9B62661C984A
P2860
The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: a report on the medical research council UKALLR1 study.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
The UK experience in treating ...... esearch council UKALLR1 study.
@en
The UK experience in treating ...... esearch council UKALLR1 study.
@nl
type
label
The UK experience in treating ...... esearch council UKALLR1 study.
@en
The UK experience in treating ...... esearch council UKALLR1 study.
@nl
prefLabel
The UK experience in treating ...... esearch council UKALLR1 study.
@en
The UK experience in treating ...... esearch council UKALLR1 study.
@nl
P2093
P2860
P1476
The UK experience in treating ...... esearch council UKALLR1 study.
@en
P2093
G Harrison
P J Darbyshire
S E Lawson
S Richards
P2860
P304
P356
10.1046/J.1365-2141.2000.01891.X
P407
P577
2000-03-01T00:00:00Z